Company intelligence / Profile preview

Aptest

Ownership: Private
Development stage: Commercial

Overview

There is no record of a life science/biopharma/healthcare company named “Aptest.” The closest match is “Aptus Biotech,” an active Spanish biotech startup specializing in developing biotechnological applications using aptamers. It provides selection services and collaborates on R&D projects focused mainly on diagnostics and therapeutics within immunology and genetics. The firm spun out the clinical-stage drug developer aptaTargets, but does not itself have a disclosed proprietary product pipeline. It remains privately held with headquarters in Madrid.

Therapeutic areas: Immunology
Modalities: AptamerPotentially others related to aptamer-based diagnostics/therapeutics
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Aptest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aptest.

Explore the full profile